Arcadia Biosciences Balance Sheet - Annual (NASDAQ:RKDA)

Add to My Stocks
$0.72 $0.01 (1.64%) RKDA stock closing price Apr 21, 2017 (Closing)

The financial analysis of a company involves interpreting the income statement, balance sheet and cash flow statements of the company to draw insights like we've done in our Arcadia Biosciences stock analysis. As in our Arcadia Biosciences stock analysis, analyzing a company also involves looking at the company's assets and liabilities as given in its balance sheet, which can be used to measure financial performance. Quarterly results announcements include the release of all three financial statements, of which the balance sheet is one. Arcadia Biosciences balance sheet as at the end of 2016 indicates an asset turnover ratio of 0.04M and debt to equity ratio of 1.13M. Whereas, Arcadia Biosciences revenue was $3.18M and Arcadia Biosciences operating cash flow was $-17.05M for the same period. View latest and last 10 year balance sheet data to check Arcadia Biosciences financial performance..

show more
Fiscal year is Jan - Dec. 2016 2015 2014 2013
Cash2.01M23.97M16.57M2.83M
Marketable Securities48.54M26.27M--
Receivables0.53M0.78M1.42M1.02M
Inventory0.25M0.29M0.42M0.45M
Raw Materials----
Work In Progress----
Finished Goods----
Notes Receivable----
Other Current Assets0.87M0.69M0.27M0.25M
Arcadia Biosciences Total Current Assets
52.22M52.01M18.69M4.56M
Property Plant & Equipment5.44M5.24M5.38M5.27M
Accumulated Depreciation4.94M4.65M4.65M4.33M
Arcadia Biosciences Net Property Plant & Equipment
0.5M0.58M0.72M0.94M
Investment & Advances2.49M19.74M0.5M1.43M
Other Non-Current Assets1.32M1.86M2.14M2.53M
Deferred Charges----
Intangibles----
Deposits & Other Assets0.01M0.02M2.81M0.06M
Arcadia Biosciences Total Assets
56.57M74.24M24.88M9.54M
Notes Payable--5.6M4.56M
Accounts Payable2.35M2.42M3.19M2.51M
Current Portion Long-Term Debt----
Current Portion Capital Leases----
Accrued Expenses----
Income Taxes Payable----
Other Current Liabilities0.77M1.02M2.46M2.46M
Arcadia Biosciences Total Current Liabilities
3.12M3.45M11.26M9.54M
Mortgages----
Deferred Taxes/Income3.12M2.63M3.63M4.37M
Convertible Debt----
Long-Term Debt25.12M24.93M8.86M9.92M
Non-Current Capital Leases----
Other Long-Term Liabilities3M3M3M3M
Arcadia Biosciences Total Liabilities
34.37M34.01M26.77M26.83M
Minority Interest----
Preferred Stock--82.88M-
Common Stock Net0.04M0.04M--
Capital Surplus173.72M172.22M29.2M78.33M
Retained Earnings-151.55M-131.92M-113.97M-95.63M
Treasury Stock----
Other Liabilities-0.01M-0.11M--
Arcadia Biosciences Shareholders Equity
22.19M40.22M-1.88M-17.29M
Arcadia Biosciences Total Liabilities & Shareholders Equity
56.57M74.24M24.88M9.54M
All figures in USD. M: Millions of USD, B: Billions of USD.
Get Balance sheet for another ticker

The latest Arcadia Biosciences stock price, and Arcadia Biosciences historical stock prices show the stock price movement over time, and the Arcadia Biosciences PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:
  • Assets: Anything that the Arcadia Biosciences company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. Arcadia Biosciences had total assets of $56.57M.
  • Liabilities: This item on the balance sheet implies the firm's, in this case Arcadia Biosciences's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for RKDA stock stand at $34.37M.
.

Arcadia Biosciences Balance Sheet - Key Ratios

Current ratio
16.74
Debt to Equity ratio
1.13
Asset Turnover
ratio
0.04
receivables turnover
ratio
6.38
PB ratio (
price to book ratio
)
1.0060